Using Virtual Reality for Patients With Gastrointestinal Disease

Not Applicable

• Conditions: Gastrointestinal Disease; Inflammatory Bowel Diseases
• Interventions: Other: Standard Practice; Other: HealthVoyager

• Registration Number: NCT03719209
• Lead Sponsor: Boston Children's Hospital

Brief Summary

The primary aim of this study is to evaluate the effect and impact of a technology which creates a virtual reality (VR), personalized representation of a patient's endoscopic findings in comparison our standard practice (SP). Our study will compare the level of knowledge, understanding and satisfaction the patient and family have between those receiving SP and those receiving both SP and VR.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-09-01
• Status Verified: 2018-10
• Study First Submitted: 2018-10-07
• Study First Submitted QC: 2018-10-24
• Study First Posted: 2018-10-25
• Last Update Submitted: 2019-05-07
• Last Update Posted: 2019-05-09
• Primary Completion: 2019-08
• Study Completion: 2019-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Patients aged 8-25 years of age who are willing and able to participate
• Patients who recently had an endoscopic procedure at Boston Children's Hospital

Exclusion Criteria

• Patients who are unable to provide consent due to age or developmental status

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Standard Practice	Standard Practice	Patients and families will be shown images of their endoscopic procedure per standard practice.
Virtual Reality	HealthVoyager	Patients and families will be showed the results of their endoscopic procedure via a virtual reality application called HealthVoyager, in addition to standard practice images.

Primary Outcome Measures

Name	Time	Method
Patient and family knowledge, understanding, and satisfaction	1 month	Our study will measure the levels of patient and family engagement using a survey designed specifically for the study. The survey is at a roughly 3rd grade reading level and includes approximately 10 questions with answers on a Likert scale. The internally designed survey will specifically measure patient and family opinions on learning about the results of their procedure, as well as objective anatomical knowledge. The minimum score for each question is a 1, designating "Strongly disagree." The maximum score for each question is a 10, designating "Strongly agree." Thus, higher scores represent better outcomes.

Secondary Outcome Measures

Name	Time	Method
Patient Satisfaction Scale	1 month	The Patient Satisfaction Scale (Hojat et al., 2011) will be used to measure patient satisfaction. The Patient Satisfaction Scale is a validated survey with 10 questions. Respondents can answer 1 through 7 for each question. 1 represents "Strongly Disagree" while 7 represents "Strongly Agree." Higher score represent better outcomes in this scale.
Longitudinal Readmission Rate	up to 5 years	Readmission rates will be measured via retrospective chart review and hospital admission data.
Longitudinal Medication Adherence	up to 5 years	Medication Adherence will be assessed via retrospective chart review and medication refill data.
Client Satisfaction Questionnaire	1 month	The Client Satisfaction Questionnaire (Larsen et al., 1979) will measure client satisfaction. The questionnaire has 8 questions with 4 possible answers for each question. A 4 represents the best possible outcome; a 1 represents the worst possible outcome.

Trial Locations

Locations (1)

Boston Children's Hospital; 🇺🇸 Boston, Massachusetts, United States